Viscira, a leading provider of interactive, new-media communication solutions and software products for the life sciences industry, announced impressive business results for 1H 2014 that concluded on June 30. Overall, the company realized a 72% percent increase in revenue for the first six months of the year versus the same period in 2013.
In addition, Viscira's 1H 2014 revenue reflects the best first-half results the company has had since its inception. Over this period, the company also maintained solid profitability metrics with minimal debt on the balance sheet.
This growth was driven by several factors, including new business from many existing clients and brands, particularly within the oncology therapeutic area. Additionally, the company brought on several new clients during this time, including AstraZeneca, Sunovion, Alexion, and InterMune.
The increased demand has been balanced across the company's entire portfolio of software products and digital solutions, including its Prospero™ Online Speaker Portal, 3D mechanism of action animations, and Vilumina™ KOL video presentation modules. Demand for the company's distinctive iPad sales aid applications also grew significantly over the period. This includes the company's innovative work on Veeva iRep platform with its vDetail solution.
"We are definitely pleased with our results for the first half of this year," said Dave Gulezian, President & CEO of Viscira. "Our teams continue to work very hard to raise the bar and innovate within the digital space in our industry. This strong first-half performance puts us in a great position to realize our ambitious business goals for the year."